Literature DB >> 14215919

A COMPARATIVE STUDY OF THE SUSCEPTIBILITY TO ETHIONAMIDE, THIOSEMICARBAZONE, AND ISONIAZID OF TUBERCLE BACILLI FROM PATIENTS NEVER TREATED WITH ETHIONAMIDE OR THIOSEMICARBAZONE.

T T HOK.   

Abstract

Entities:  

Keywords:  DRUG RESISTANCE, MICROBIAL; ETHIONIAMIDE; EXPERIMENTAL LAB STUDY; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; PHARMACOLOGY; THIOSEMICARBAZONES

Mesh：

Substances：

Year:  1964        PMID： 14215919     DOI： 10.1164/arrd.1964.90.3.468

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  6 in total

1.  Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.

Authors:  Nicole Ritz; Marc Tebruegge; Tom G Connell; Aina Sievers; Roy Robins-Browne; Nigel Curtis
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

2.  [The significance of tubercle bacillis resistance against lowered ethionamide concentrations for successful treatment].

Authors:  D Vána; M Slosárek
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1967

3.  Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria.

Authors:  Catherine Vilchèze; Torin R Weisbrod; Bing Chen; Laurent Kremer; Manzour H Hazbón; Feng Wang; David Alland; James C Sacchettini; William R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 4.  Antimicrobial agent resistance in mycobacteria: molecular genetic insights.

Authors:  J M Musser
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

5.  ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates.

Authors:  Glenn P Morlock; Beverly Metchock; David Sikes; Jack T Crawford; Robert C Cooksey
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 6.  Tuberculosis: Past, present and future of the treatment and drug discovery research.

Authors:  Ameya D Bendre; Peter J Peters; Janesh Kumar
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.